Obe-cel demonstrates high remission rates in pediatric patients with high-risk r/r B-ALL with overall response rate (ORR) of 95.5%; low rates of high-grade cytokine release syndrome (CRS) and immune ...
Genetix Biotherapeutics Inc. today announced real-world data from the commercial implementation of ZYNTEGLOtm and LYFGENIAtm, first-in-class ex vivo gene addition therapies for the treatment of ...
Modern analytical data to support upcoming interpretation, drill targeting and updated geological modelling VANCOUVER, BC / ...
Let's be real here. Most of us toss old phones and computers into a drawer and forget they exist. Some go straight to the ...
Deepest 150+ gram metre intercept to date at Glenburgh Gold Project takes Zone 126 down to 800m verticalHIGHLIGHTS: Lens 4 ...
In late September 2025, the American tech giant Microsoft went so far as to block Israel's elite signals intelligence unit, ...